Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals

Neurology

Volumn 59, Issue 3, 2002, Pages 342-347

  De Luca, A ^a   Ciancio, B C ^a   Larussa, D ^a   Murri, R ^a   Cingolani, A ^a   Rizzo, M G ^a   Giancola, M L ^b   Ammassari, A ^a   Ortona, L ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION;

EID: 0037072312     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.3.342     Document Type: Article

References (35)

1. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection
2. HIV in body fluids during primary HIV infection: Implications for pathogenesis, treatment and public health
3. Pathways to neuronal injury and apoptosis in HIV-associated dementia
4. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: Relevance for HIV-1-associated dementia
5. Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy
6. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: Support for the hypothesis of local virus replication
7. Cerebrospinal fluid HIV-1 originates from both local CNS and systemic sources
8. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid
9. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples
10. Comparison of HIV-1 viral sequences in brain, choroid plexus and spleen: Potential role of choroid plexus in the pathogenesis of HIV encephalitis
11. HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with abacavir
12. Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymphnode CD4+ T cells
13. HIV infection of the central nervous system is characterized by rapid turn-over of viral RNA in the cerebrospinal fluid
14. Rapid clearance of human immunodeficiency virus type 1 from ventricular cerebrospinal fluid during antiretroviral treatment
15. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain
16. MCP-1 and CCR2 in HIV infection: Regulation of agonist and receptor expression
17. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication
18. Selective elevation of monocyte chemotactic protein-1 (MCP-1) in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis
19. Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population
20. Sanctuary sites in HIV-1 infection
21. Diagnosis of AIDS-related focal brain lesions: A decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF
22. Antiretroviral drugs and the central nervous system
23. Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1 patients
24. Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir
25. Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine
26. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy
27. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir
28. Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: A randomized controlled trial
29. The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy
30. Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: A mass balance study
31. Antiretroviral treatment of central nervous system HIV-1 infection: A review
32. Presence of mutation conferring resistance to lamivudine in plasma and cerebrospinal fluid of HIV-1-infected patients
33. Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy
34. Decay characteristics of HIV-1-infected compartments during combination therapy
35. CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing